GURUFOCUS.COM » STOCK LIST » USA » NYSE » Alcon Inc (NYSE:ALC) » Definitions » ROCE %
Switch to:

Alcon ROCE %

: 2.79% (As of Jun. 2022)
View and export this data going back to 2019. Start your Free Trial

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Alcon's annualized ROCE % for the quarter that ended in Jun. 2022 was 2.79%.

Alcon ROCE % Historical Data

The historical data trend for Alcon's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alcon Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
ROCE %
Premium Member Only -0.39 -1.09 -0.87 -2.02 2.12

Alcon Quarterly Data
Dec16 Dec17 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
ROCE % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.47 0.13 2.65 3.59 2.79

Alcon ROCE % Calculation

Alcon's annualized ROCE % for the fiscal year that ended in Dec. 2021 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2021 )  (A: Dec. 2020 )(A: Dec. 2021 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2021 )  (A: Dec. 2020 )(A: Dec. 2021 )
=538/( ( (27600 - 2258) + (27999 - 2472) )/ 2 )
=538/( (25342+25527)/ 2 )
=538/25434.5
=2.12 %

Alcon's ROCE % of for the quarter that ended in Jun. 2022 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Jun. 2022 )  (Q: Mar. 2022 )(Q: Jun. 2022 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Jun. 2022 )  (Q: Mar. 2022 )(Q: Jun. 2022 )
=712/( ( (27790 - 2247) + (27727 - 2320) )/ 2 )
=712/( ( 25543 + 25407 )/ 2 )
=712/25475
=2.79 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2022) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alcon  (NYSE:ALC) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Alcon ROCE % Related Terms

Thank you for viewing the detailed overview of Alcon's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Alcon Business Description

Alcon logo
Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Alcon Inc (NYSE:ALC) » Definitions » ROCE %
Comparable Companies
XSWX:STMN XSWX:TECN XSWX:YPSN XSWX:SKAN XSWX:CLTN XSWX:VBSN NAS:ISRG NYSE:BDX XPAR:EL TSE:7741 NYSE:BAX XPAR:DIM NYSE:RMD TSE:7733 TSE:4543 OCSE:COLO B NYSE:WST NAS:HOLX NYSE:COO SZSE:300896
Traded in Other Exchanges
ALC:Mexico 0A0D:UK ALC:Switzerland
Address
Chemin de Blandonnet 8, Royce Bedward, Vernier, Geneva, CHE, 1214
Website
https://www.alcon.com
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun-off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.

Alcon Headlines

From GuruFocus

Alcon Reinforces Strength of Industry-Leading Ophthalmology Portfolio with Largest Surgical Device Scientific Presence at ASCRS 2021

By Business Wire 07-22-2021

Harding Loevner Lp Buys Alcon Inc, Accenture PLC, XP Inc, Sells Itau Unibanco Holding SA, Alibaba Group Holding, eBay Inc

By insider 02-15-2022

Alcon Announces Broad Retail Availability of Pataday Once Daily Relief Extra Strength in the U.S.

By Business Wire 02-18-2021

Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio

By Business Wire 11-08-2021

Bellecapital International Ltd. Buys Nomad Foods, iShares J.P. Morgan EM Corporate Bond ETF, iShares MSCI Emerging Markets Asia Index Fund, Sells Tencent Music Entertainment Group, iShares MSCI All Country Asia ex Japan Index Fund, iShares iBonds Dec 2021

By insider 01-20-2022

swisspartners Ltd. Buys Stellantis NV, Deere, The Mosaic Co, Sells Stellantis NV, Zoetis Inc,

By insider 08-13-2021

Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio

By Business Wire 01-10-2022

Banque Cantonale Vaudoise Buys Alcon Inc, Logitech International SA, Alphabet Inc, Sells iShares MSCI Brazil ETF, Companhia Siderurgica Nacional, Moderna Inc

By insider 10-29-2021

Alcon Launches Systane Hydration Multi-Dose Preservative-Free Lubricant Eye Drops in the U.S.

By Business Wire 04-28-2021

Alcidion Group Stock Shows Every Sign Of Being Significantly Overvalued

By GF Value 04-16-2021

Other Sources

QIAGEN (QGEN) New Launch to Aid Global TB Elimination Targets

By Zacks 2021-10-20

Abbott's (ABT) Organic Sales Grow Amid Spike in COVID Cases

By Zacks 2021-10-25

Here's Why You Should Retain Bio-Rad (BIO) Stock For Now

By Zacks 2021-10-20

Alcon's (ALC) Global Growth Solid, New Lenses Sales Rise

By Zacks 2022-01-19

Alcon (ALC) Launches Preservative-Free Drops for Dry Eye Relief

By Zacks 2022-01-14

Hologic (HOLX) to Expand Surgical Portfolio With Bolder Buyout

By Zacks 2021-10-18

Alcon (ALC) Surgical Arm Grows Amid Global Trade Disruption

By Zacks 2021-11-23

STERIS (STE) Hits a New 52-Week High: What's Driving It?

By Zacks 2021-10-22

$ALC - Alcon Inc. 2021 Q4 - Results - Earnings Call Presentation. Alcon Inc 2021 Q4 Results Earnings Call Presentation

By Seekingalpha 2022-02-16

Abbott's (ABT) Nutrition Arm in Focus on Real Madrid Alliance

By Zacks 2021-10-19

Alcon (ALC) on Track With Successful Global PRECISION1 Rollout

By Zacks 2021-12-16

Alcon (ALC) Publishes Dividend, New Board Member Addition Plans

By Zacks 2022-03-28

$ALC - Alcon Inc. (ALC) CEO David Endicott on Q4 2021 Results - Earning Call Transcript. Alcon Inc Alc Ceo David Endicott On Q4 2021 Results Earning Call Transcript

By Seekingalpha 2022-02-16

Alcon (ALC) Expands in the U.S. With New Clareon IOLs Launch

By Zacks 2022-03-08

Alcon (ALC) Vision Care Sales Grow Despite Supply Disruption

By Zacks 2021-12-28

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)